SCHEMBL29402

SCHEMBL29402

COCCC=C(C#N)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.38
KDM4E B2RXH2 4/20 0.38
KMT2A Q03164 2/20 0.38
PKM P14618 1/20 0.38
ALDH1A1 P00352 3/20 0.36
HPGD P15428 2/20 0.36
MEN1 O00255 1/20 0.36
MITF O75030 1/20 0.36
MAPK1 P28482 1/20 0.36
MDM2 Q00987 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.34
POLB P06746 1/20 0.34
CISD1 Q9NZ45 1/20 0.33
SLC16A3 O15427 1/20 0.33
CYP3A4 P08684 1/20 0.33
SLC16A1 P53985 1/20 0.33
GPR35 Q9HC97 1/20 0.33
EGFR P00533 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28680213 0.90 LMNA (0.35) LMNAKDM4EKMT2APKMALDH1A1
SCHEMBL718912 0.89 ALDH1A1 (0.38) LMNAKDM4EKMT2APKMALDH1A1
SCHEMBL31624856 0.86 ALDH1A1 (0.43) LMNAKDM4EKMT2APKMALDH1A1
SCHEMBL28672469 0.83 LMNA (0.33) LMNAKDM4EKMT2APKMALDH1A1
SCHEMBL20395650 0.83 ALDH1A1 (0.43) LMNAALDH1A1
SCHEMBL30580 0.81 CYP2C9 (0.38) LMNAKDM4EKMT2APKMALDH1A1
SCHEMBL3203194 0.80 KDM4E (0.33) LMNAKDM4EKMT2APKMALDH1A1
SCHEMBL28712282 0.80 KDM4E (0.33) LMNAKDM4EKMT2APKMALDH1A1
SCHEMBL3240748 0.80 CYP2C9 (0.33) LMNAKDM4EKMT2APKMPOLB
SCHEMBL15309080 0.80 KDM4E (0.40) LMNAKDM4EKMT2APKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025119862-A1 COMPOSITION COMPRISING N-HEPTYLCYANOACRYLATE BOSTIK SA (FR) 2025-06-12 WO claimed
EP-4567084-A1 COMPOSITION COMPRISING N-HEPTYLCYANOACRYLATE Bostik SA (FR) 2025-06-11 EP claimed
US-11897978-B2 Hybrid light-curing composition DYMAX CORPORATION (US) 2024-02-13 US claimed
EP-3691860-B1 PHOTORESPONSIVE MATERIALS FOR VOLUMETRIC ADDITIVE MANUFACTURING ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) 2023-07-19 EP claimed
EP-3941989-A1 CYANOACRYLATE ADHESIVE COMPOSITION Henkel AG & Co. KGaA (DE) 2022-01-26 EP claimed
US-20220002590-A1 Cyanoacrylate Adhesive Composition HENKEL AG & CO KGAA (DE) 2022-01-06 US claimed
US-20210363393-A1 ADHESIVE COMPOSITION THAT EASILY DISINTEGRATES IN WATER TOAGOSEI CO., LTD. (JP) 2021-11-25 US claimed
US-20210301045-A1 HYBRID LIGHT-CURING COMPOSITION DYMAX CORPORATION 2021-09-30 US claimed
EP-3750961-A1 ADHESIVE COMPOSITION THAT EASILY DISINTEGRATES IN WATER Toagosei Co., Ltd. (JP) 2020-12-16 EP claimed
WO-2020191510-A1 CYANOACRYLATE ADHESIVE COMPOSITION HENKEL AG & CO. KGAA (DE) 2020-10-01 WO claimed
WO-2003064483-A1 RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS HENKEL CORPORATION (US) 2003-08-07 WO claimed
EP-0963420-A4 RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS LOCTITE CORP (US) 2003-01-15 EP claimed
US-6433036-B1 METALLOCENE AND PHOTOINITIATOR; EXPOSURE TO ELECTROMAGNETIC RADIATION LOCTITE CORPORATION 2002-08-13 US claimed
EP-0795420-B1 Lithographic printing plate adapted to be imaged by ablation KODAK POLYCHROME GRAPHICS LLC (US) 2001-03-28 EP claimed
EP-0963420-A1 RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS LOCTITE CORPORATION (US) 1999-12-15 EP claimed
WO-1998038260-A9 RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS 1999-02-11 WO claimed
WO-1998038260-A1 RADIATION-CURABLE, CYANOACRYLATE-CONTAINING COMPOSITIONS LOCTITE CORPORATION (US) 1998-09-03 WO claimed
US-5691114-A Method of imaging of lithographic printing plates using laser ablation EASTMAN KODAK COMPANY (US) 1997-11-25 US claimed
EP-0795420-A1 Lithographic printing plate adapted to be imaged by ablation EASTMAN KODAK COMPANY (US) 1997-09-17 EP claimed
US-5605780-A ANODIZED ALUMINUM SUPPORT, IMAGE FORMING LAYER COMPRISING INFRARED ABSORBING AGENT DISPERSED IN CYANOACRYLATE BINDER EASTMAN KODAK COMPANY (US) 1997-02-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210301045-A1 HYBRID LIGHT-CURING COMPOSITION MUS81, MAT2B, MAT1A LMNA 1479/4885KDM4E 1835/4885KMT2A 455/4885
US-11897978-B2 Hybrid light-curing composition MUS81, MAT2B, MAT1A LMNA 1479/4885KDM4E 1835/4885KMT2A 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.